المؤلفون: Li W; Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland.; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Hua B; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Saud SM; Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland., Lin H; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Hou W; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Matter MS; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Jia L; Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Colburn NH; Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland., Young MR; Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland.

المصدر: Molecular carcinogenesis [Mol Carcinog] 2015 Oct; Vol. 54 (10), pp. 1096-109. Date of Electronic Publication: 2014 May 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

مواضيع طبية MeSH: AMP-Activated Protein Kinases/*metabolism , Berberine/*pharmacology , Carcinogenesis/*drug effects , Colon/*drug effects , Colorectal Neoplasms/*drug therapy , Signal Transduction/*drug effects, Animals ; Apoptosis/drug effects ; Azoxymethane/pharmacology ; Carcinogenesis/metabolism ; Carcinogenesis/pathology ; Caspase 3/metabolism ; Cell Line, Tumor ; Colon/metabolism ; Colon/pathology ; Colorectal Neoplasms/metabolism ; Cyclin D1/metabolism ; Cyclooxygenase 2/metabolism ; Female ; HCT116 Cells ; Humans ; Mice ; NF-kappa B/metabolism ; Phosphorylation/drug effects ; Protein Serine-Threonine Kinases/metabolism ; TOR Serine-Threonine Kinases/metabolism ; Tumor Suppressor Protein p53/metabolism ; eIF-2 Kinase/metabolism

المؤلفون: Li, Weidong, Hua, Baojin, Saud, Shakir M., Lin, Hongsheng, Hou, Wei, Matter, Matthias S., Jia, Libin, Colburn, Nancy H., Young, Matthew R.

مصطلحات موضوعية: Berberine, Carcinogenesis, Caspase 3, Colon, TOR Serine-Threonine Kinases, Azoxymethane, NF-kappa B, Apoptosis, AMP-Activated Protein Kinases, Protein Serine-Threonine Kinases, HCT116 Cells, Article, Mice, eIF-2 Kinase, Cyclooxygenase 2, Cell Line, Tumor, Animals, Humans, Cyclin D1, Female, Phosphorylation, Tumor Suppressor Protein p53, Colorectal Neoplasms, Signal Transduction

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::e4a427c959fe0ba7bff02b0e0b663a60
https://europepmc.org/articles/PMC4504840/